Minimum Investment
₹137,200
Price Range
₹326 to ₹343
Lot Size
400 shares
Issue Size
₹214 Cr
About the Company
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Bookbuilding IPO
IPO Objectives
- To meet working capital requirements
- Repayment of certain borrowing availed by the Company, in part or full
- General Corporate Purposes
Important Dates
| Bid/Offer Opens On | 21-05-2026 |
| Bid/Offer Closes On | 25-05-2026 |
| Finalisation of Basis of Allotment | 26-05-2026 |
| Initiation of Refunds | 27-05-2026 |
| Credit of Shares to Demat | 27-05-2026 |
| IPO Listing Date | 29-05-2026 |
IPO Subscription Status
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 1,188,000 | 147,237,200 | 123.94x |
| NII | 891,600 | 130,466,800 | 146.33x |
| NII ( >10 lakh) | 594,400 | 106,289,200 | 178.82x |
| NII ( <10 lakh) | 297,200 | 24,177,600 | 81.35x |
| Retail | 2,079,200 | 0 | 0.00x |
| Total | 4,158,800 | 277,704,000 | 66.78x |
Grey Market Premium (GMP)
₹124.00
per share
Registrar
Purva Sharegistry (India) Pvt.Ltd.
Lead Managers
- Hem Securities Ltd.
- Share India Capital Services Pvt.Ltd.
Company Promoters
- The promoters of the company are Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty and Abhay Agrawal.\r\n
